User profile

Meredith Hanel

Medical Genetics PhD, following life science applications that improve the health of humans and our planet.
Joined May 2018
ContributionsFavoritesActivity
Autoimmune diseaseAutoimmune disease was edited byMeredith HanelMeredith Hanel
January 31, 2021 9:20 pm
Article  (+412 characters)

Further companies in autoimmune disease field not yet added to above query table:

Kanaph Therapeutics

Karma Biotechnologies

Kezar Life Sciences

Landos Biopharma

MiroBio

Mozart Therapeutics

Ossium Health

Polyneuron Pharmaceuticals

Precigen

Q32 Bio

Rheos Medicines

SDI Labs - Specialty Diagnostic Laboratories

Shanghai Henlius Biotech

Thync

Topas Therapeutics

Ventus Therapeutics

Vera Therapeutics

Viela Bio

Visionary Pharmaceuticals

INNOVATE BIOPHARMACEUTICALS, INC.
was edited byMeredith HanelMeredith Hanel
January 31, 2021 9:07 pm
Article  (+50 characters)

Innovate Biopharmaceuticals was the name of a clinical stage biotechnology company focused on developing therapeutics for autoimmune and inflammatory diseases. In 2019 Innovate merged with RDD Pharma and renamed the company 9 Meters Biopharma. 9 Meters is focused on gastrointestinal diseases.

9 Meters Biopharma9 Meters Biopharma was edited byMeredith HanelMeredith Hanel
January 31, 2021 9:06 pm

9 Meters Biopharma

Biopharmaceutical company focused on the gastrointestinal diseases

Article  (+212 characters)

9 Meters Biopharma is named for the approximate length of the digestive tract. The company formed from a merge between Innovate Biopharmaceuticals and RDD Pharma. 9 Meters is focused on gastrointestinal diseases.

Infobox
Location
Raleigh, North Carolina
INNOVATE BIOPHARMACEUTICALS, INC.
was edited byMeredith HanelMeredith Hanel
January 31, 2021 8:58 pm

INNOVATE BIOPHARMACEUTICALS, INC.

Innovate Biopharmaceuticals was the name of a clinical stage biotechnology company focused on developing therapeutics for autoimmune and inflammatory diseases. In 2019 Innovate merged with RDD Pharma and renamed the company 9 Meters Biopharma.

Article  (+243 characters)

Innovate Biopharmaceuticals was the name of a clinical stage biotechnology company focused on developing therapeutics for autoimmune and inflammatory diseases. In 2019 Innovate merged with RDD Pharma and renamed the company 9 Meters Biopharma.

Infobox
9 Meters Biopharma9 Meters Biopharma was edited byMeredith HanelMeredith Hanel
"Initial creation data"
January 31, 2021 8:58 pm
Infobox
9 Meters Biopharma9 Meters Biopharma was created byMeredith HanelMeredith Hanel
"Created via: Web app"
January 31, 2021 8:58 pm
9 Meters Biopharma

9 Meters Biopharma

Biopharmaceutical company focused on the gastrointestinal diseases

InnoCareInnoCare was edited byMeredith HanelMeredith Hanel
January 31, 2021 8:49 pm
Topic thumbnail

InnoCare

InnoCare Pharma is a clinical-stage biopharmaceutical company in the discovery, development and commercialization of treatments for cancer and autoimmune diseases.

Article  (+163 characters)

InnoCare Pharma is a clinical-stage biopharmaceutical company in the discovery, development and commercialization of treatments for cancer and autoimmune diseases.

Infobox
Location
Inmedix
was edited byMeredith HanelMeredith Hanel
January 31, 2021 8:43 pm

Inmedix

Biotechnology and medical device company in the therapeutic area of autoimmune disease and has research programs in rheumatoid arthritis, fibromyalgia and multiple sclerosis

Article  (+499 characters)

Inmedix is a biotechnology and medical device company in the therapeutic area of autoimmune disease and has research programs in rheumatoid arthritis, fibromyalgia and multiple sclerosis.Inmedix works under the premise that stress, managed within the brain by the autonomic nervous system (ANS), drives immune activity to excess, a process they call Immuno-autonomics. ANS Neuroscan is a heart rate variability device and diagnostic tool in autoimmune disease for patients with rheumatoid arthritis.

Inmedix
was edited byMeredith HanelMeredith Hanel
"Initial creation data"
January 31, 2021 8:21 pm
Infobox
Inmedix
was created byMeredith HanelMeredith Hanel
"Created via: Web app"
January 31, 2021 8:21 pm

Inmedix

Biotechnology and medical device company in the therapeutic area of autoimmune disease and has research programs in rheumatoid arthritis, fibromyalgia and multiple sclerosis

ImmunoVision
was edited byMeredith HanelMeredith Hanel
January 31, 2021 8:19 pm

ImmunoVision

ImmunoVIsion is a subsidiary of Erba Diagnostics and supplies reagents to the autoimmune research field.

Article  (+104 characters)

ImmunoVIsion is a subsidiary of Erba Diagnostics and supplies reagents to the autoimmune research field.

Immunovant
was edited byMeredith HanelMeredith Hanel
January 31, 2021 8:16 pm

Immunovant

Clinical-stage biopharmaceutical company developing treatments for autoimmune diseases

Article  (+103 characters)

Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases.

Infobox
Immunovant
was edited byMeredith HanelMeredith Hanel
"Initial creation data"
January 31, 2021 8:12 pm
Immunovant
was created byMeredith HanelMeredith Hanel
"Created via: Web app"
January 31, 2021 8:12 pm

Immunovant

Clinical-stage biopharmaceutical company developing treatments for autoimmune diseases

Immunic TherapeuticsImmunic Therapeutics was edited byMeredith HanelMeredith Hanel
January 31, 2021 8:11 pm

Immunic Therapeutics

Clinical-stage biopharmaceutical company developing oral immunology therapies that are small molecule products for treatment of chronic inflammatory and autoimmune diseases multiple sclerosis, ulcerative colitis, Crohn’s disease and psoriasis

Article  (+269 characters)

Immunic Therapeutics is a clinical-stage biopharmaceutical company developing oral immunology therapies that are small molecule products for treatment of chronic inflammatory and autoimmune diseases multiple sclerosis, ulcerative colitis, Crohn’s disease and psoriasis.

Infobox
Immunic TherapeuticsImmunic Therapeutics was edited byMeredith HanelMeredith Hanel
"Initial creation data"
January 31, 2021 8:06 pm
Immunic TherapeuticsImmunic Therapeutics was created byMeredith HanelMeredith Hanel
"Created via: Web app"
January 31, 2021 8:06 pm
Immunic Therapeutics

Immunic Therapeutics

Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including relapsing-remitting multiple sclerosis, ulcerative colitis, Crohn’s disease, and psoriasis.

Immune RegulationImmune Regulation was edited byMeredith HanelMeredith Hanel
January 31, 2021 8:02 pm
Topic thumbnail

Immune Regulation

Clinical stage biotech company developing technologies to reset the immune system and therapies for inflammatory and immunological diseases

Article  (+358 characters)

Immune Regulation is a clinical stage biotech company developing technologies to reset the immune system and therapies for inflammatory and immunological diseases. Immune Regulation was formerly known as Peptinnovate. Clinical programs include rheumatoid arthritis and asthma and the company aims to apply their treatments to a range of autoimmune disorders.

HotSpot Therapeutics
was edited byMeredith HanelMeredith Hanel
January 31, 2021 5:11 pm

HotSpot Therapeutics

Biotechnology company developing medicines that target allosteric regulatory sites on proteins

Article  (+581 characters)

HotSpot Therapeutics target regulatory mechanisms to create allosteric medicines such as small molecule molecules for treatment of autoimmune and rare diseases as well as cancer. The company’s SpotFinder technology platform is used to identify and target regulatory hotspots, a unique family of pockets situated remotely from the active site on a protein that are normally used in the body to control protein function. HotSpot’s lead compounds include allosteric inhibitors targeting PKC-theta for autoimmune diseases and S6 kinase involved in mitochondrial and metabolic function.

Hengrui TherapeuticsHengrui Therapeutics was edited byMeredith HanelMeredith Hanel
January 31, 2021 4:59 pm
Topic thumbnail

Hengrui Therapeutics

Biotechnology company focused on early-stage clinical development of therapies in areas of unmet medical needs in oncology, metabolic and autoimmune disorders

Article  (+195 characters)

Hengrui Therapeutics Inc (HTI) is a biotechnology company focused on early-stage clinical development of therapies in areas of unmet medical needs in oncology, metabolic and autoimmune disorders.

Golden logo